Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute
Completed
- Conditions
- Healthy
- Registration Number
- NCT00314470
- Lead Sponsor
- AHS Cancer Control Alberta
- Brief Summary
The purpose of this study is to retrospectively have access to image files of patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Subject 18 years of age and over
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does NCT00314470's dosimetry research enhance radiation therapy precision in oncology?
What imaging biomarkers in NCT00314470 correlate with treatment response in cancer patients?
How does NCT00314470's retrospective analysis compare to prospective dosimetry studies in radiation oncology?
What adverse events are associated with high-dose radiation protocols evaluated in NCT00314470?
How does NCT00314470's medical physics approach influence drug development for radiation-sensitive tumors?
Trial Locations
- Locations (1)
Cross Cancer Institute
🇨🇦Edmonton, Alberta, Canada